Take Your Trading To The Next Level. Get Started Here!
+1 (949) 514 8188
Bristol Myers Squibb said it agreed to buy biopharmaceutical company Karuna Therapeutics for $14 billion in cash.
Karuna Therapeutics surges 47% after Bristol Myers Squibb announces $14 billion deal
Bristol Myers Squibb said it agreed to buy biopharmaceutical company Karuna Therapeutics for $14 billion in cash.
Archives
Categories
Archives
Recent Posts
Meta
Categories
Calender